Adapting Clinical Practice to a Rapidly Changing Therapeutic Landscape in Multiple Myeloma

Download All
In this comprehensive program centered on an in-person and online live CCO symposium at ASH 2021, experts discuss recent developments in management of multiple myeloma. Review their insights in clinical commentaries, along with an on-demand webcast and downloadable slides from the symposium. In addition, listen to the audio podcast to hear the experts answer audience questions and download a treatment algorithm to use in your clinic.
Brian G.M. Durie, MD
Thomas G. Martin, MD
Philippe Moreau, MD
S. Vincent Rajkumar, MD
Jesus San-Miguel, MD, PhD

Downloadable Slidesets

Download this slideset based on the content from the annual CCO/IMF satellite symposium at ASH on diagnosis and management of patients with smoldering multiple myeloma.

Jesus San-Miguel, MD, PhD Released: December 15, 2021

Download this slideset based on the content from the annual CCO/IMF satellite symposium at ASH on selecting optimal therapy for patients with newly diagnosed multiple myeloma who are eligible for ASCT.

Philippe Moreau, MD Released: December 15, 2021

Download this slideset based on the content from the annual CCO/IMF satellite symposium at ASH on selecting optimal therapy for patients with newly diagnosed multiple myeloma who are not eligible for ASCT.

Philippe Moreau, MD Released: December 15, 2021

Download this slideset based on the content from the annual CCO/IMF satellite symposium at ASH on treatment selection for patients with multiple myeloma in first relapse.

S. Vincent Rajkumar, MD Released: December 15, 2021

Download this slideset based on content from the annual CCO/IMF satellite symposium at ASH on treatment options for patients with heavily pretreated, relapsed/refractory multiple myeloma, excluding BCMA-targeted agents.

Brian G.M. Durie, MD Released: December 15, 2021

Download this slideset based on content from the annual CCO/IMF satellite symposium at ASH on a new 2022 treatment algorithm for patients with multiple myeloma.

Philippe Moreau, MD S. Vincent Rajkumar, MD Released: December 15, 2021

Download this slideset based on content from the annual CCO/IMF satellite symposium at ASH on BCMA-targeted treatment options for patients with relapsed/refractory multiple myeloma.

Thomas G. Martin, MD Released: December 15, 2021

Gain key clinical insights fast, with this short slideset from CCO on key considerations for optimal treatment of multiple myeloma.

Brian G.M. Durie, MD Thomas G. Martin, MD Philippe Moreau, MD S. Vincent Rajkumar, MD Jesus San-Miguel, MD, PhD Released: January 4, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
Bristol-Myers Squibb
Genentech, a member of the Roche Group
GlaxoSmithKline
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Karyopharm Therapeutics
Oncopeptides
Pfizer, Inc.
Sanofi Genzyme

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings